Cargando…
_version_ 1783716151739547648
author Nanaa, Ahmad
Viswanatha, David
Xie, Zhuoer
Jevremovic, Dragan
Nguyen, Phuong
Salama, Mohamad E.
Greipp, Patricia
Bessonen, Kurt
Gangat, Naseema
Patnaik, Mrinal
Pardanani, Animesh
Alkhateeb, Hassan B.
Shah, Mithun
Hogan, William
Tefferi, Ayalew
Litzow, Mark
He, Rong
Al-Kali, Aref
author_facet Nanaa, Ahmad
Viswanatha, David
Xie, Zhuoer
Jevremovic, Dragan
Nguyen, Phuong
Salama, Mohamad E.
Greipp, Patricia
Bessonen, Kurt
Gangat, Naseema
Patnaik, Mrinal
Pardanani, Animesh
Alkhateeb, Hassan B.
Shah, Mithun
Hogan, William
Tefferi, Ayalew
Litzow, Mark
He, Rong
Al-Kali, Aref
author_sort Nanaa, Ahmad
collection PubMed
description
format Online
Article
Text
id pubmed-8245641
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82456412021-07-20 Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience Nanaa, Ahmad Viswanatha, David Xie, Zhuoer Jevremovic, Dragan Nguyen, Phuong Salama, Mohamad E. Greipp, Patricia Bessonen, Kurt Gangat, Naseema Patnaik, Mrinal Pardanani, Animesh Alkhateeb, Hassan B. Shah, Mithun Hogan, William Tefferi, Ayalew Litzow, Mark He, Rong Al-Kali, Aref Blood Cancer J Correspondence Nature Publishing Group UK 2021-06-30 /pmc/articles/PMC8245641/ /pubmed/34193836 http://dx.doi.org/10.1038/s41408-021-00517-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Nanaa, Ahmad
Viswanatha, David
Xie, Zhuoer
Jevremovic, Dragan
Nguyen, Phuong
Salama, Mohamad E.
Greipp, Patricia
Bessonen, Kurt
Gangat, Naseema
Patnaik, Mrinal
Pardanani, Animesh
Alkhateeb, Hassan B.
Shah, Mithun
Hogan, William
Tefferi, Ayalew
Litzow, Mark
He, Rong
Al-Kali, Aref
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience
title Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience
title_full Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience
title_fullStr Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience
title_full_unstemmed Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience
title_short Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience
title_sort clinical and biological characteristics and prognostic impact of somatic gata2 mutations in myeloid malignancies: a single institution experience
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245641/
https://www.ncbi.nlm.nih.gov/pubmed/34193836
http://dx.doi.org/10.1038/s41408-021-00517-0
work_keys_str_mv AT nanaaahmad clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT viswanathadavid clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT xiezhuoer clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT jevremovicdragan clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT nguyenphuong clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT salamamohamade clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT greipppatricia clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT bessonenkurt clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT gangatnaseema clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT patnaikmrinal clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT pardananianimesh clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT alkhateebhassanb clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT shahmithun clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT hoganwilliam clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT tefferiayalew clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT litzowmark clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT herong clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience
AT alkaliaref clinicalandbiologicalcharacteristicsandprognosticimpactofsomaticgata2mutationsinmyeloidmalignanciesasingleinstitutionexperience